Search - tctmd.com

Displaying 361 - 380 of 3622

Sort: Relevancy | Date

Presentation EuroPCR 2024

Sirolimus vs paclitaxel DCB. A logistic regression analysis of EASTBOURNE and PEARL multicentre study

Presenter: Bernardo Cortese

May 14, 2024

Presentation Fellows 2024

Cutting-Edge Techniques in DCB Lesion Prep and Treatment

Presenter: Jeffrey W. Moses

April 13, 2024

Presentation Fellows 2024

Wire/Balloon/Catheter/Stent Technology: Fundamentals of Design and Use

Presenter: Margaret B. McEntegart

April 12, 2024

Presentation ACC 2024

Primary Results from the Phase 2 KARDIA-2 Study

Presenter: Akshay Desai

April 07, 2024

Presentation THT 2024

Designing a Bionic Heart

Presenter: Ellen Roche

March 06, 2024

Presentation THT 2024

New Endpoints and Experimental Designs for Devices for Chronic Heart Failure (Breakthrough)

Presenter: William T. Abraham

March 06, 2024

Presentation THT 2024

A Novel Study Design, Termed Molecular Triangulation, That Leverages Biologic Similarities Across Seemingly Different Shock Phenotypes In Order to Identify Novel Druggable Targets and Pathophysiologic Mechanisms.

Presenter: Thomas Hanff

March 06, 2024

Presentation THT 2024

Remote PA Pressure Monitoring: Where are we now and where are we going?

Presenter: Akshay Desai

March 05, 2024

Presentation THT 2024

Designing Clinical Trials to Facilitate Better Implementation: Tips for Researchers

Presenter: Harriette G.C. Van Spall

March 05, 2024

Presentation THT 2024

A Phase 1 Clinical Gene Therapy Trial in Patients With Advanced Heart Failure Using a Rationally Designed Cardiotropic AAV Vector Targeting Protein Phosphatase Inhibitor-1

Presenter: Lothar Roessig

March 05, 2024

Presentation THT 2024

Remote Patient Monitoring: Implications for Management of HF Patients During the Next Decade

Presenter: Akshay Desai

March 05, 2024

Presentation THT 2024

Inhibition of Hepatic Angiotensinogen Synthesis by an RNA Interference Therapeutic Agent: Implications for HTN and HF

Presenter: Akshay Desai

March 05, 2024

Presentation THT 2024

BrioHealth Solutions: Pump and Clinical Trial Design

Presenter: James Long

March 04, 2024

Presentation Miami Valves 2024

Modern PCI: Achieve Optimal Treatment with AGENT DCB

Presenter: Yiannis S. Chatzizisis

February 03, 2024

Presentation Miami Valves 2024

AGENT™ Drug-Coated Balloon

Presenter: John M. Lasala

February 03, 2024

Presentation CTO 2024

The Dawn of Drug Coated Balloons, In-stent Restenosis, and Beyond

Presenter: Ajay J. Kirtane

February 03, 2024

Presentation CTO 2024

Breaking Barriers in Bifurcation PCI With Low LVEF: DES + DCB With Pioneering Percutaneous Ventricular Assist Device

Presenter: Carlos Campos

February 03, 2024

Presentation CTO 2024

Doubling the Risk: Prognostic Impact of Chronic Total Occlusions in the Left Anterior Descending Artery—Insights From a Population-Based Cohort Study

Presenter: Emil Nielsen Holck

February 02, 2024

Presentation Miami Valves 2024

Multicenter Randomized Trial Comparing the AGENT Paclitaxel-Coated Balloon With Conventional Balloon Angioplasty for In-Stent Restenosis

Presenter: Thomas E. Noel

February 01, 2024

Presentation Miami Valves 2024

AGENT DCB Clinical Data

Presenter: Nicolas M. Van Mieghem

February 01, 2024

Advertisement

Sirolimus vs paclitaxel DCB. A logistic regression analysis of EASTBOURNE and PEARL multicentre study

Cutting-Edge Techniques in DCB Lesion Prep and Treatment

Wire/Balloon/Catheter/Stent Technology: Fundamentals of Design and Use

Primary Results from the Phase 2 KARDIA-2 Study

Designing a Bionic Heart

New Endpoints and Experimental Designs for Devices for Chronic Heart Failure (Breakthrough)

A Novel Study Design, Termed Molecular Triangulation, That Leverages Biologic Similarities Across Seemingly Different Shock Phenotypes In Order to Identify Novel Druggable Targets and Pathophysiologic Mechanisms.

Remote PA Pressure Monitoring: Where are we now and where are we going?

Designing Clinical Trials to Facilitate Better Implementation: Tips for Researchers

A Phase 1 Clinical Gene Therapy Trial in Patients With Advanced Heart Failure Using a Rationally Designed Cardiotropic AAV Vector Targeting Protein Phosphatase Inhibitor-1

Remote Patient Monitoring: Implications for Management of HF Patients During the Next Decade

Inhibition of Hepatic Angiotensinogen Synthesis by an RNA Interference Therapeutic Agent: Implications for HTN and HF

BrioHealth Solutions: Pump and Clinical Trial Design

Modern PCI: Achieve Optimal Treatment with AGENT DCB

AGENT™ Drug-Coated Balloon

The Dawn of Drug Coated Balloons, In-stent Restenosis, and Beyond

Breaking Barriers in Bifurcation PCI With Low LVEF: DES + DCB With Pioneering Percutaneous Ventricular Assist Device

Doubling the Risk: Prognostic Impact of Chronic Total Occlusions in the Left Anterior Descending Artery—Insights From a Population-Based Cohort Study

Multicenter Randomized Trial Comparing the AGENT Paclitaxel-Coated Balloon With Conventional Balloon Angioplasty for In-Stent Restenosis

AGENT DCB Clinical Data

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content